Avicenna.AI receives FDA 510(k) clearance for cervical spine fracture AI tool
Key takeaways:
- Avicenna.AI announced FDA 510(k) clearance of its CINA-CSpine tool.
- The CINA-CSpine tool utilizes AI algorithms to detect and assess cervical spine fractures.
Avicenna.AI announced FDA 510(k) clearance of its CINA-CSpine tool for patients with cervical spine fractures, according to a company press release.
The CINA-CSpine tool uses deep learning and machine learning algorithms to detect and assess cervical spine fractures on CT imaging, according to the release.

“Cervical spine fractures are serious injuries that require prompt and appropriate medical attention, especially if the spinal cord is involved, so accurate diagnosis is essential,” Cyril Di Grandi, co-founder and CEO of Avicenna.AI, said in the release. “With CINA-CSpine, we aim to help reduce the delay between scan and interpretation, which is critical in the treatment of this condition.”